Funds raised for next stage of Diurnal development
Diurnal, a portfolio company of AIM-listed Fusion IP, has raised £1.2 million of new capital as well as completing Phase I trails of its lead product Chronocort.
News
Diurnal, a portfolio company of AIM-listed Fusion IP, has raised £1.2 million of new capital as well as completing Phase I trails of its lead product Chronocort.
News